CARLSON INV. ZY 13 (2HB) - Net Assets
Based on the latest financial reports, CARLSON INV. ZY 13 (2HB) has net assets worth €27.21 Million EUR (≈ $31.81 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.33 Million ≈ $33.13 Million USD) and total liabilities (€1.12 Million ≈ $1.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See 2HB equity to assets ratio to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €27.21 Million |
| % of Total Assets | 96.04% |
| Annual Growth Rate | -4.74% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 40.89 |
CARLSON INV. ZY 13 - Net Assets Trend (2021–2025)
This chart illustrates how CARLSON INV. ZY 13's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is CARLSON INV. ZY 13 worth.
Annual Net Assets for CARLSON INV. ZY 13 (2021–2025)
The table below shows the annual net assets of CARLSON INV. ZY 13 from 2021 to 2025. Also explore 2HB net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €27.21 Million ≈ $31.81 Million |
+70.85% |
| 2024-12-31 | €15.93 Million ≈ $18.62 Million |
-33.72% |
| 2023-12-31 | €24.03 Million ≈ $28.09 Million |
-5.91% |
| 2022-12-31 | €25.54 Million ≈ $29.86 Million |
-22.71% |
| 2021-12-31 | €33.04 Million ≈ $38.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CARLSON INV. ZY 13's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11526909000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €153.31 Million | 563.39% |
| Total Equity | €27.21 Million | 100.00% |
CARLSON INV. ZY 13 Competitors by Market Cap
The table below lists competitors of CARLSON INV. ZY 13 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nandani Creation Limited
NSE:JAIPURKURT
|
$4.62 Million |
|
Instituto Rosenbusch S.A.
BA:ROSE
|
$4.62 Million |
|
Prolexus Bhd
KLSE:8966
|
$4.63 Million |
|
Belmont Resources Inc
V:BEA
|
$4.64 Million |
|
Huachen AI Parking Management Technology Holding Co Ltd
NASDAQ:HCAI
|
$4.61 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
$4.61 Million |
|
DSS Inc
NYSE MKT:DSS
|
$4.59 Million |
|
WORK Medical Technology Group LTD Ordinary Shares
NASDAQ:WOK
|
$4.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CARLSON INV. ZY 13's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 15,706,885 to 27,213,029, a change of 11,506,144 (73.3%).
- Net income of 25,055 contributed positively to equity growth.
- New share issuances of 2,093,600 increased equity.
- Other factors increased equity by 9,387,489.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €25.05K | +0.09% |
| Share Issuances | €2.09 Million | +7.69% |
| Other Changes | €9.39 Million | +34.5% |
| Total Change | €- | 73.26% |
Book Value vs Market Value Analysis
This analysis compares CARLSON INV. ZY 13's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.17x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €4.14 | €0.50 | x |
| 2022-12-31 | €3.15 | €0.50 | x |
| 2023-12-31 | €2.62 | €0.50 | x |
| 2024-12-31 | €1.71 | €0.50 | x |
| 2025-12-31 | €2.95 | €0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CARLSON INV. ZY 13 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.09%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.29%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 1.04x
- Recent ROE (0.09%) is above the historical average (-1.32%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -1.69% | -7.19% | 0.20x | 1.17x | €-3.85 Million |
| 2022 | 8.42% | 37.44% | 0.17x | 1.30x | €-396.03K |
| 2023 | -4.18% | -13.03% | 0.26x | 1.22x | €-3.33 Million |
| 2024 | -9.22% | -256.23% | 0.03x | 1.30x | €-3.02 Million |
| 2025 | 0.09% | 2.29% | 0.04x | 1.04x | €-2.70 Million |
Industry Comparison
This section compares CARLSON INV. ZY 13's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $24,948,769,416
- Average return on equity (ROE) among peers: -1633.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CARLSON INV. ZY 13 (2HB) | €27.21 Million | -1.69% | 0.04x | $4.61 Million |
| China Cinda Asset Management Co., Ltd. (0CI) | $223.66 Billion | 1.59% | 6.70x | $1.46 Billion |
| Quinsam Capital Corporation (0Q4) | $12.24 Million | -16.47% | 0.01x | $2.01 Million |
| tokentus investment AG (14D) | $9.00 Million | -25.95% | 0.02x | $6.90 Million |
| TEAM PLC (1WQ) | $7.44 Million | -22.94% | 0.33x | $14.75 Million |
| JTC PLC LS-01 (2N9) | $344.62 Million | 7.73% | 0.80x | $2.65 Billion |
| Rostra AG (3330) | $4.00K | -14688.58% | 53.94x | $8.82 Million |
| HELIOS FAIRFAX PARTNERS (3UD) | $456.90 Million | 8.87% | 0.05x | $105.95 Million |
| ALEXANDRIA PANKKIIRILIIKE (3ZL) | $37.35 Million | 20.82% | 0.46x | $157.84 Million |
| HAMILTON GLB.OPP.LS-0001 (5DS) | $14.39 Million | 9.30% | 0.04x | $24.13 Million |
About CARLSON INV. ZY 13
Carlson Investments SE is a venture capital firm specializing in seed, early, growth capital and pre-IPO investments. The firm prefer to make investments in financial, medical, and deep technology industries. The firm seeks to make investments in Europe, North America and Asia, with a particular focus on Central and Eastern Europe. The company was formerly known as Hotblok S.A. and changed its na… Read more